Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Anbio Biotechnology Class...

    NASDAQ: NNNN · Real-Time Price · USD
    8.66
    -0.14 (-1.59%)
    At close: Jun 13, 2025, 3:59 PM
    8.90
    2.77%
    After-hours: Jun 13, 2025, 05:41 PM EDT

    Anbio Biotechnology Class A Ordinary Shares Statistics

    Share Statistics

    Anbio Biotechnology Class A Ordinary Shares has 43.89M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 43.89M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 3,014

    FTD / Avg. Volume

    n/a
    		 4.61%

    Short Selling Information

    The latest short interest is 22.52K, so 0.05% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 22.52K

    Short % of Shares Out

    n/a
    		 0.05%

    Short % of Float

    n/a
    		 0.05%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is 102.84 and the forward PE ratio is null. Anbio Biotechnology Class A Ordinary Shares's PEG ratio is 0.4.

    PE Ratio

    n/a
    		 102.84

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 29.81

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 14.19

    P/FCF Ratio

    n/a
    		 117.3

    PEG Ratio

    n/a
    		 0.4
    Financial Ratio History

    Enterprise Valuation

    Anbio Biotechnology Class A Ordinary Shares has an Enterprise Value (EV) of 232.26M.

    EV / Sales

    n/a
    		 28.38

    EV / EBITDA

    n/a
    		 90.49

    EV / EBIT

    n/a
    		 111.64

    EV / FCF

    n/a
    		 111.64

    Financial Position

    The company has a current ratio of 10.71, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 10.71

    Quick Ratio

    n/a
    		 10.71

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 13.8% and Return on Invested Capital is 11.61%.

    Return on Equity

    n/a
    		 13.8%

    Return on Assets

    n/a
    		 12.54%

    Return on Invested Capital

    n/a
    		 11.61%

    Revenue Per Employee

    n/a
    		 $303,153.56

    Profits Per Employee

    n/a
    		 $87,883.04

    Employee Count

    n/a
    		 27

    Asset Turnover

    n/a
    		 0.43

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 1.8, so Anbio Biotechnology Class A Ordinary Shares's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.8

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 7.22

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 70.01

    Average Volume (20 Days)

    n/a
    		 65,311

    Income Statement

    In the last 12 months, Anbio Biotechnology Class A Ordinary Shares had revenue of 8.19M and earned 2.37M in profits. Earnings per share was 0.06.

    Revenue

    n/a
    		 8.19M

    Gross Profit

    n/a
    		 5.89M

    Operating Income

    n/a
    		 2M

    Net Income

    n/a
    		 2.37M

    EBITDA

    n/a
    		 2.57M

    EBIT

    n/a
    		 2.37M

    Earnings Per Share (EPS)

    n/a
    		 0.06
    Full Income Statement

    Balance Sheet

    The company has 11.76M in cash and 0 in debt, giving a net cash position of 11.76M.

    Cash & Cash Equivalents

    n/a
    		 11.76M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 17.17M

    Total Assets

    n/a
    		 n/a

    Working Capital

    n/a
    		 n/a
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 2.08M and capital expenditures 0, giving a free cash flow of 2.08M.

    Operating Cash Flow

    n/a
    		 2.08M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 2.08M

    FCF Per Share

    n/a
    		 0.05
    Full Cash Flow Statement

    Margins

    Gross margin is 71.9%, with operating and profit margins of 24.38% and 28.99%.

    Gross Margin

    n/a
    		 71.9%

    Operating Margin

    n/a
    		 24.38%

    Pretax Margin

    n/a
    		 28.99%

    Profit Margin

    n/a
    		 28.99%

    EBITDA Margin

    n/a
    		 31.36%

    EBIT Margin

    n/a
    		 24.38%

    FCF Margin

    n/a
    		 25.42%

    Dividends & Yields

    NNNN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 0.97%

    FCF Yield

    n/a
    		 0.85%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for NNNN.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 0.72

    Graham Upside

    n/a
    		 -91.69%

    Scores

    Altman Z-Score

    n/a
    		 n/a

    Piotroski F-Score

    n/a
    		 n/a

    Add to Watchlist